Sarepta Therapeutics Inc (SRPT)
Debt-to-capital ratio
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Long-term debt | US$ in thousands | — | — | — | — | — |
| Total stockholders’ equity | US$ in thousands | 1,527,740 | 859,337 | 384,950 | 928,009 | 761,759 |
| Debt-to-capital ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
December 31, 2024 calculation
Debt-to-capital ratio = Long-term debt ÷ (Long-term debt + Total stockholders’ equity)
= $—K ÷ ($—K + $1,527,740K)
= 0.00
The debt-to-capital ratio for Sarepta Therapeutics Inc has consistently remained at 0.00 from December 31, 2020, to December 31, 2024. This indicates that the company has not utilized debt as a significant portion of its capital structure during this period. A debt-to-capital ratio of 0.00 suggests that the company has financed its operations primarily through equity rather than debt. This low ratio may reflect a conservative approach to financial risk management, as it implies lower financial leverage and potential interest expenses. However, it's essential to consider other financial metrics and qualitative factors to gain a more comprehensive understanding of the company's overall financial health and capital structure strategy.
Peer comparison
Dec 31, 2024